---
layout: post
title: FDA批准针对奥秘克戎的新冠加强针，预计很快向公众提供
date: 2022-09-01 08:33:04.000000000 +08:00
link: https://cn.wsj.com/amp/articles/fda%E6%89%B9%E5%87%86%E9%92%88%E5%AF%B9%E5%A5%A5%E7%A7%98%E5%85%8B%E6%88%8E%E7%9A%84%E6%96%B0%E5%86%A0%E5%8A%A0%E5%BC%BA%E9%92%88-%E9%A2%84%E8%AE%A1%E5%BE%88%E5%BF%AB%E5%90%91%E5%85%AC%E4%BC%97%E6%8F%90%E4%BE%9B-11661989805
categories: wsj
---

<main id="main" role="main">
<div>


</div>
<div itemprop="articleLead" data-sbId="CN-BGH-20220901073958">
    <div>
      <div class="media-object scope-
          header
">
          <figure>
      <div>
        <img
          srcset="https://images.wsj.net/im-611115?width=540&amp;size=1.5005861664712778 540w, https://images.wsj.net/im-611115?width=620&amp;size=1.5005861664712778 620w, https://images.wsj.net/im-611115?width=639&amp;size=1.5005861664712778 639w, https://images.wsj.net/im-611115?width=860&amp;size=1.5005861664712778 860w, https://images.wsj.net/im-611115?width=860&amp;size=1.5005861664712778&amp;pixel_ratio=1.5 1290w, https://images.wsj.net/im-611115?width=860&amp;size=1.5005861664712778&amp;pixel_ratio=2 1720w, https://images.wsj.net/im-611115?width=860&amp;size=1.5005861664712778&amp;pixel_ratio=3 2580w"
          src="https://images.wsj.net/im-611115?width=860&amp;height=573"
          layout="responsive"
          placeholder
          alt="">
        </img>
      </div>
      <figcaption>
        <p>该批准标志着新冠疫苗自2020年12月开始在美国分发以来，其组成成分首次做出调整。</p>
    <p> 图片来源：EMILY ELCONIN/REUTERS</p>
  </figcaption>
</figure>

      </div>
    </div>
</div>
<div data-sbId="CN-BGH-20220901073958">

<div>

  <div>
      <p> </p>
              <p><span itemprop="name">
                <a href="https://www.wsj.com/news/author/jared-s-hopkins" itemprop="url" rel="author">Jared S. Hopkins</a>
              </span> / </p>
            <p><span itemprop="name">
                <a href="https://www.wsj.com/news/author/liz-essley-whyte" itemprop="url" rel="author">Liz Essley Whyte</a>
              </span></p>

  </div>
    <time>
      2022年9月1日07:50 CST 更新
    </time>
</div>

<div>
  <social-share type="system" width="72" height="24"
    data-param-url="https://cn.wsj.com/articles/fda批准针对奥秘克戎的新冠加强针-预计很快向公众提供-11661989805">
  </social-share>
</div>


<div subscriptions-section="content">
</div>
<div subscriptions-section="content-not-granted">
</div>



<section subscriptions-section="content">
      <p>美国卫生监管机构批准了针对奥密克戎最新变异株的新版新冠疫苗，为可能在几天内展开的秋季加强针接种运动做好准备。</p>
      <p>美国食品药品管理局(FDA)周三采取行动后，12岁及以上人群将可在最近一次接种至少两个月后再接种辉瑞公司(Pfizer Inc., PFE)和BioNTech SE (BNTX)的一剂额外加强针，而18岁及以上人群也可接种Moderna Inc. (MRNA)的加强针。</p>
      <p>该批准标志着新冠疫苗自2020年12月开始在美国分发以来，<a href="https://cn.wsj.com/articles/CN-BGH-20220629075554" target="_blank" >其组成成分首次做出调整</a>。</p>
      <div> <p>在民众开始接种这些疫苗之前，为美国疾病控制与预防中心(The Centers for Disease Control and Prevention, 简称CDC)提供建议的一个疫苗专家小组定于周四和周五开会，讨论FDA的授权。</p>
      <p>许多医院、药店和其他疫苗接种点会在该小组讨论和CDC主任签字批准后开始提供疫苗。</p>
      </div>
</section>

</div>
      </main>
